XML 20 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Share capital
Contributed surplus
Accumulated other comprehensive income (loss)
Retained earnings
Balance (in shares) at Jan. 03, 2016   243,572,000      
Balance at Jan. 03, 2016 $ 2,188,443 $ 150,497 $ 14,007 $ 1,093 $ 2,022,846
Changes in equity [abstract]          
Share-based compensation 15,225   15,225    
Shares issued under employee share purchase plan (in shares)   53,000      
Shares issued under employee share purchase plan 1,532 $ 1,532      
Shares issued pursuant to exercise of stock options (in shares)   77,000      
Shares issued pursuant to exercise of stock options 825 $ 1,278 (453)    
Shares issued or distributed pursuant to vesting of restricted share units (in shares)   291,000      
Shares issued or distributed pursuant to vesting of restricted share units $ (4,696) $ 7,632 (12,185)   (143)
Shares repurchased for cancellation (note 13(d)) (in shares) (13,775,248) (13,775,000)      
Shares repurchased for cancellation (note 13(d)) $ (394,451) $ (8,626)     (385,825)
Change in classification of non-Treasury RSUs to equity-settled 6,234   6,234    
Dividends declared (74,382)   370   (74,752)
Transactions with shareholders of the Company recognized directly in equity (in shares)   (13,354,000)      
Transactions with shareholders of the Company recognized directly in equity (449,713) $ 1,816 9,191   (460,720)
Cash flow hedges (note 14(d)) 39,518     39,518  
Actuarial loss on employee benefit obligations (note 12(a)) (5,239)       (5,239)
Net earnings 346,638       346,638
Comprehensive income $ 380,917     39,518 341,399
Balance (in shares) at Jan. 01, 2017 230,218,171 230,218,000      
Balance at Jan. 01, 2017 $ 2,119,647 $ 152,313 23,198 40,611 1,903,525
Changes in equity [abstract]          
Share-based compensation 15,706   15,706    
Shares issued under employee share purchase plan (in shares)   58,000      
Shares issued under employee share purchase plan 1,671 $ 1,671      
Shares issued pursuant to exercise of stock options (in shares)   269,000      
Shares issued pursuant to exercise of stock options 3,390 $ 5,304 (1,914)    
Shares issued or distributed pursuant to vesting of restricted share units (in shares)   364,000      
Shares issued or distributed pursuant to vesting of restricted share units $ (4,520) $ 7,709 (12,229)   0
Shares repurchased for cancellation (note 13(d)) (in shares) (11,512,267) (11,512,000)      
Shares repurchased for cancellation (note 13(d)) $ (328,616) $ (7,692)     (320,924)
Change in classification of non-Treasury RSUs to equity-settled 0        
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (in shares)   (198,000)      
Share repurchases for settlement of non-Treasury RSUs (note 13(e)) (6,280) $ (135)     (6,145)
Dividends declared (84,822)   447   (85,269)
Transactions with shareholders of the Company recognized directly in equity (in shares)   (11,019,000)      
Transactions with shareholders of the Company recognized directly in equity (403,471) $ 6,857 2,010   (412,338)
Cash flow hedges (note 14(d)) (27,071)     (27,071)  
Actuarial loss on employee benefit obligations (note 12(a)) (64)       (64)
Net earnings 362,334       362,334
Comprehensive income $ 335,199     (27,071) 362,270
Balance (in shares) at Dec. 31, 2017 219,198,989 219,199,000      
Balance at Dec. 31, 2017 $ 2,051,375 $ 159,170 $ 25,208 $ 13,540 $ 1,853,457